Why Attend?

Preliminary Agenda
CLE

FDLI’s 2020 Annual Conference Goes Virtual!

FDLI is excited to provide the key industry updates and the opportunity to connect with the food and drug law community that you have come to expect from the Annual Conference, just in a virtual format.  While we will miss seeing each other in person, a virtual format allows the whole food and drug law community to participate regardless of safety concerns, location, time zone, or budget constraints.  

We look forward to hosting an array of experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, and academia over the span of three shortened days to address the complex legal, regulatory, compliance, and policy issues currently impacting all facets of FDA-regulated industry. Please note that all tobacco topics will be covered in the Tobacco Conference also being held in October.

 

Keynote Address
Dr. Stephen M. Hahn, Commissioner of Food and Drugs, FDA (Invited)

 

 

 

Conference Highlights: 

  • Hear FDA’s strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency and the impacts COVID-19 has had on priorities moving forward
  • Gain in-depth knowledge of each FDA Center by attending consecutive Center Director sessions scheduled to maximize attendee participation
  • Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding in the post-COVID era
  • Select from over 30 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals

Key FDA Speakers:

  • Stacy Cline Amin, Chief Counsel, FDA (Invited)
  • Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA 
  • Susan T. Mayne, Director, Center for Food Safety and Applied Nutrition, FDA 
  • Jeffrey E. Shuren, Director, Center for Devices and Radiological Health, FDA
  • Steven M. Solomon, Director, Center for Veterinary Medicine, FDA (Invited)
  • Patrizia Cavazzoni, Acting Director, Center for Drug Evaluation and Research, FDA (Invited)

Last Year’s Attendees

0
FDA Officials
0
Manufacturer Representatives
0
Expert Speakers
  • Food and Drug Attorneys
  • In-House Counsel
  • Senior Regulatory and Policy Professionals
  • Government Officials
  • Compliance Officers and Counsel
  • Food and Drug Industry Consultants
  • Regulatory Affairs Professionals
  • Government Affairs Professionals
  • Chief Safety Officers
  • Academics
  • Consumer Advocates
  • Patient Advocates 
  • Business Development Professionals
  •  Global Strategy Professionals 
  • Venture Capitalists 
  • Corporate Planning Staff

70+ Years of FDLI Serving the Food and Drug Community

Register

Industry & Firms

$299
  • +$100 for non-members

Non-Profit

$299
  • +$100 for non-members

Government

$299
  • +$100 for non-members

Academic

$299
  • +$100 for non-members

Student

$99
  • full-time students only
Register Now

 

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

The change of date means that the Annual Conference will now be held two weeks prior to the Tobacco and Nicotine Products Regulation and Policy Conference, scheduled for October 22-23. For this year only, we have made the decision to move tobacco-specific sessions from the Annual Conference to the Tobacco Conference. In addition, Center updates from Mitchell Zeller, Director of FDA’s Center for Tobacco Products, will also be provided at the Tobacco Conference. If you are interested in tobacco-related programming, we hope you will join us at that conference: Learn more here.

Does Your FDLI Membership Qualify You for a Complimentary or Discounted Registration?

Member manufacturers, suppliers and distributors with more than $1 billion in sales as well as member law firms get one complimentary registration as part of their annual membership dues. Member manufacturers, suppliers and distributors with less than $1 billion in sales get one registration at 50% off as part of their annual membership dues. To take advantage of these opportunities, please contact us.

To ensure that FDLI is able to provide you with a seat, materials, and meals, please register for programs at least 48 hours in advance. While onsite registration is available on a “space-available” basis; late registrants are not guaranteed materials or meals.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.

FDLI remains committed to hosting an Annual Conference that is engaging and accessible for all members of the food and drug law community. If you are a full-time student, recent graduate not yet employed, full-time employee or volunteer leader of a 501(c)(3) patient organization, or are currently experiencing financial hardship, you may qualify for a full or partial registration waiver.

 

Apply Now

Sponsorship Opportunities

Sponsorship opportunities are available. Please let us know if you would like more information

 

Premier Sponsor

 

Notebook Sponsor

 

Lanyard Sponsor

 

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

 

Silver Sponsor

Silver Sponsor

Silver Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

Bronze Sponsor

 

Bronze Sponsor

 

Bronze Sponsor

 

Bronze Sponsor

 

Bronze Sponsor

 

Bronze Sponsor

Exhibitor

 

Exhibitor

Planning Committee

Co-Chairs

 

James Czaban
Partner, Loeb & Loeb LLP

 

Adora Ndu
Vice President, Regulatory Affairs, Policy, Research, Engagement (PRE) & Reg International, BioMarin Pharmaceutical Inc.

Committee

Wade Ackerman, Partner, Covington & Burling LLP
David Bloch, Principal Legal Counsel, Corporate Legal Regulatory, Medtronic
Jeff Chasnow, Senior Vice President and Associate General Counsel, Pfizer, Inc.
Sandra Eskin, Project Director, Food Safety, Pew Charitable Trusts
Azim Chowdhury, Partner, Keller and Heckman LLP
Kathleen Hoke, Professor & Director, Network for Public Health Policy and Center for Tobacco Regulation, University of Maryland Carey School of Law
Jonathan Havens, Partner, Saul Ewing Arnstein & Lehr LLP
Erika Lietzan, Associate Professor, University of Missouri-Columbia School of Law
John A. Murphy, Deputy General Counsel, Biotechnology Innovation Organization 
Meredith Olearchik, Vice President and Associate General Counsel, Intellectual Property, Marketing and Food Law, Campbell Soup Company
Suzan Onel, Partner, Kleinfeld, Kaplan & Becker LLP
Stuart Pape, Shareholder, Polsinelli
Lauren Roth, Acting Associate Commissioner for Policy, Office of the Commissioner, FDA
Deborah Shelton, Partner, Arent Fox LLP
David Spangler, Senior Vice President, Policy and General Counsel, Consumer Healthcare Products Association (CHPA)
Marta Villaraga, Principal, Exponent, Inc.
Armando Zamora, Acting Deputy Director of ORA’s Office of Planning and Policy, FDA

Call For Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this Fall. The input received from industry stakeholders helps us plan a timely program.